首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1457956

全球多重檢測市場：市場規模和佔有率分析（依產品、類型和技術）、工業需求預測（截至 2030 年）

Multiplex Assays Market Size and Share Analysis by Product, Type, Technology - Global Industry Demand Forecast to 2030

出版日期: 2024年02月01日 | 出版商:

Prescient & Strategic Intelligence | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球多重檢測市場將以 9.0% 的複合年增長率成長，到 2023 年達到 39.18 億美元，到 2030 年達到 71.035 億美元。

其背景是慢性病和傳染病的快速增加。另一個關鍵因素是對研究和臨床診斷中開發的分析平台的需求不斷增長，以減少研究人員、患者和醫療保健提供者的成本。

依細分市場分析

依產品劃分，消耗品類別在 2023 年以 45% 的佔有率引領產業。這是由於診斷測試數量的增加和生命科學公司研究活動的增加。

從技術角度來看，多重即時 PCR 類別將在未來幾年內以 9.4% 的速度成長最快。這是由於不同類型的 PCR 系統的快速可用性。

亞太地區成為成長最快的地區

由於醫院數量不斷增加、產業投資不斷增加以及對已開發醫療基礎設施的高需求，亞太地區正在以最快的速度發展。中國也是該地區成長最快的國家。

北美將佔據該行業的最大佔有率，到2023年將佔55%的佔有率，並將在未來幾年取得重大進展。這是由於製藥和生物技術公司為開發新藥和診斷解決方案而增加的研發活動。

本報告分析了全球多重檢測市場，包括市場的基本結構和最新情況、主要促進和抑制因素以及全球、依地區和主要國家的市場規模前景（以貨幣形式計算），2017-2030），依產品、類型和技術劃分的詳細趨勢、市場競爭現狀以及主要公司概況。

This is because of the surging incidence of chronic ailments as well as infectious diseases. Furthermore, the rising demand for developed analytical platforms in research and clinical diagnostics, to decrease the expenses for researchers, patients, and healthcare providers is also a key contributor.

According to the World Health Organization, chronic diseases including cancer, cardiovascular diseases, respiratory illnesses, and diabetes, will account for 86% of the 90 million deaths annually by around 2050, a significant increase of 90% since 2019.

Moreover, there were an estimated 249 million cases of malaria and 608,000 deaths from this disease in 85 nations in 2022. In addition, in the same year, there were around 39 million individuals with HIV globally. Of these, 1.5 million were children (below 15 years of age), and 37.5 million were adults. Additionally, 53% were girls and women.

The COVID-19 pandemic has had a positive impact on the industry, by driving an enormous rise in research & development for the production of innovative solutions to detect coronavirus.

Furthermore, the surging elderly population and incidence of autoimmune ailments, cancer, and human immunodeficiency virus are likely to drive the industry growth during this decade.

Segmentation Insights

The consumables category, based on product, led the industry in 2023, with a 45% share. This is because of the increasing count of diagnostic tests and the rising research activities by life sciences businesses.

For example, in January 2023, Novo Nordisk, a pharmaceutical firm, declared a grant of USD 6 million for Durham Technical Community College.

The grant is to assist the latter's life sciences program and build a new 35,000-square-foot training center.

In 2023, the protein-based category, based on type, accounted for the largest share, of 50%, owing to the rising adoption of such products in proteomics studies. Furthermore, protein-based assays are extensively employed in research to classify the concentration of electrophoresis, cell biology, protein, and various other analytes.

The multiplex real-time PCR category, based on technology, is likely to advance at the fastest rate, of 9.4%, in the years to come. This can be ascribed to the swift launch of different variants of PCR systems.

APAC is Fastest-Growing Region

APAC is advancing at the fastest rate, because of the increasing number of hospitals, rising investment value in this industry, and high requirement for developed healthcare infrastructure. In addition, China is the fastest-growing nation in APAC.

North America was the largest contributor to the industry in 2023, with a 55% share, and it will advance significantly in the years to come. This is because of the increasing research & development activities by pharmaceutical and biotechnology firms to develop new drugs as well as diagnostic solutions.

Competition Analysis

Key players are highly focused on investments and innovations to develop panels and devices for the multiplexed detection of the virus. Also, businesses are engaging in partnerships to distribute immunometric assays.

Oxford Nanopore Technologies and 10x Genomics, in October 2022, announced a partnership to develop an efficient workflow for full-length transcript sequencing in a single read on the devices of Oxford Nanopore.

This partnership enables the integration of Oxford's Promethlon devices as well as sample preparation on 10x Genomics devices, along with selected consumables.

With the surging incidence of infectious and chronic diseases, the multiplex assays industry will grow continuously in the coming years.

Chapter 1. Research Scope

1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product
- 1.4.2. Market size breakdown, by type
- 1.4.3. Market size breakdown, by technology
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
- 1.5.1. Value
1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview
6.2. Market Revenue, by Product (2017-2030)
6.3. Market Revenue, by Type (2017-2030)
6.4. Market Revenue, by Technology (2017-2030)
6.5. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

7.1. Overview
7.2. Market Revenue, by Product (2017-2030)
7.3. Market Revenue, by Type (2017-2030)
7.4. Market Revenue, by Technology (2017-2030)
7.5. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

8.1. Overview
8.2. Market Revenue, by Product (2017-2030)
8.3. Market Revenue, by Type (2017-2030)
8.4. Market Revenue, by Technology (2017-2030)
8.5. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

9.1. Overview
9.2. Market Revenue, by Product (2017-2030)
9.3. Market Revenue, by Type (2017-2030)
9.4. Market Revenue, by Technology (2017-2030)
9.5. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

10.1. Overview
10.2. Market Revenue, by Product (2017-2030)
10.3. Market Revenue, by Type (2017-2030)
10.4. Market Revenue, by Technology (2017-2030)
10.5. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

11.1. Overview
11.2. Market Revenue, by Product (2017-2030)
11.3. Market Revenue, by Type (2017-2030)
11.4. Market Revenue, by Technology (2017-2030)
11.5. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

12.1. Overview
12.2. Market Revenue, by Product (2017-2030)
12.3. Market Revenue, by Type (2017-2030)
12.4. Market Revenue, by Technology (2017-2030)

Chapter 13. Canada Market

13.1. Overview
13.2. Market Revenue, by Product (2017-2030)
13.3. Market Revenue, by Type (2017-2030)
13.4. Market Revenue, by Technology (2017-2030)

Chapter 14. Germany Market

14.1. Overview
14.2. Market Revenue, by Product (2017-2030)
14.3. Market Revenue, by Type (2017-2030)
14.4. Market Revenue, by Technology (2017-2030)

Chapter 15. France Market

15.1. Overview
15.2. Market Revenue, by Product (2017-2030)
15.3. Market Revenue, by Type (2017-2030)
15.4. Market Revenue, by Technology (2017-2030)

Chapter 16. U.K. Market

16.1. Overview
16.2. Market Revenue, by Product (2017-2030)
16.3. Market Revenue, by Type (2017-2030)
16.4. Market Revenue, by Technology (2017-2030)

Chapter 17. Italy Market

17.1. Overview
17.2. Market Revenue, by Product (2017-2030)
17.3. Market Revenue, by Type (2017-2030)
17.4. Market Revenue, by Technology (2017-2030)

Chapter 18. Spain Market

18.1. Overview
18.2. Market Revenue, by Product (2017-2030)
18.3. Market Revenue, by Type (2017-2030)
18.4. Market Revenue, by Technology (2017-2030)

Chapter 19. Japan Market

19.1. Overview
19.2. Market Revenue, by Product (2017-2030)
19.3. Market Revenue, by Type (2017-2030)
19.4. Market Revenue, by Technology (2017-2030)

Chapter 20. China Market

20.1. Overview
20.2. Market Revenue, by Product (2017-2030)
20.3. Market Revenue, by Type (2017-2030)
20.4. Market Revenue, by Technology (2017-2030)

Chapter 21. India Market

21.1. Overview
21.2. Market Revenue, by Product (2017-2030)
21.3. Market Revenue, by Type (2017-2030)
21.4. Market Revenue, by Technology (2017-2030)

Chapter 22. Australia Market

22.1. Overview
22.2. Market Revenue, by Product (2017-2030)
22.3. Market Revenue, by Type (2017-2030)
22.4. Market Revenue, by Technology (2017-2030)

Chapter 23. South Korea Market

23.1. Overview
23.2. Market Revenue, by Product (2017-2030)
23.3. Market Revenue, by Type (2017-2030)
23.4. Market Revenue, by Technology (2017-2030)

Chapter 24. Brazil Market

24.1. Overview
24.2. Market Revenue, by Product (2017-2030)
24.3. Market Revenue, by Type (2017-2030)
24.4. Market Revenue, by Technology (2017-2030)

Chapter 25. Mexico Market

25.1. Overview
25.2. Market Revenue, by Product (2017-2030)
25.3. Market Revenue, by Type (2017-2030)
25.4. Market Revenue, by Technology (2017-2030)

Chapter 26. Saudi Arabia Market

26.1. Overview
26.2. Market Revenue, by Product (2017-2030)
26.3. Market Revenue, by Type (2017-2030)
26.4. Market Revenue, by Technology (2017-2030)

Chapter 27. South Africa Market

27.1. Overview
27.2. Market Revenue, by Product (2017-2030)
27.3. Market Revenue, by Type (2017-2030)
27.4. Market Revenue, by Technology (2017-2030)

Chapter 28. U.A.E. Market

28.1. Overview
28.2. Market Revenue, by Product (2017-2030)
28.3. Market Revenue, by Type (2017-2030)
28.4. Market Revenue, by Technology (2017-2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings
29.2. Competitive Benchmarking of Key Players
29.3. Product Benchmarking of Key Players
29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. Thermo Fisher Scientific Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
30.2. Illumina Inc.
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
30.3. Bio-Rad Laboratories Inc.
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
30.4. Qiagen N.V.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
30.5. Abcam plc
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
30.6. Becton, Dickinson and Company
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
30.7. Merck KGaA
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
30.8. Agilent Technologies Inc.
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
30.9. Meso Scale Diagnostics LLC
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary